Relevium Enters Into Manufacturing Agreement With Bio V Pharma and Registers 400 NPN Numbers With Health Canada Cannabis Investing News
Anavex Life Sciences Announces Extension of Clinical Study in Alzheimer’s Disease Biotech Investing
PreveCeutical Receives $616,802 AUD Research and Development Tax Incentive Cash Refund Cannabis Investing News
Life Science Big News Roundup: Cardiol Completes Manufacturing Scale-up for Commercialization of CardiolRx(TM)100; CannaVcell Naturally Produces Cannabis’ Active Ingredients Without Growing the Plant Life Science Investing
